Skip to main content
Caplight Logo









Skape Bio

Skape Bio

Private
CopenhagenHealthcare & Life Scienceshttps://www.skape.bio/

Last Round

Pre Seed

Sep 22, 2025

Total Funding Raised

$1.27M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Skape Bio is a biotechnology company with a drug discovery platform designed for pharmaceutical companies to unlock G protein-coupled receptors. The company's AI-driven platform unites generative protein design, native receptor biology, and scalable in-cell screening, enabling drug developers to access unreachable therapeutic targets and achieve precise receptor modulation.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

GPCR drug discoveryG protein-coupled receptorsGPCRsAI drug discoveryde novo protein designminiprotein therapeuticsgenerative biologyAI biotechdrug discovery platformcomputational protein designhigh-throughput screeningbiologics discoverypharmaceutical partnershipstherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Skape Bio Comparables

Compare Skape Bio with similar companies based on industry and business-model similarity.

Skape Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SelekTx
82%
VRG Therapeutics
82%
Fusiomica
79%

Skape Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 22, 2025

Skape Bio Investors

Notable investors and investment history

Skape Bio investors
InvestorRounds
Mission BioCapitalPre Seed
BioInnovation InstituteAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2025

    $500K round led by Mission BioCapital

Skape Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Skape Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Skape Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Year Founded2025
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?